Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Adicionar filtros








Intervalo de ano
1.
Korean Journal of Medicine ; : 507-511, 2012.
Artigo em Coreano | WPRIM | ID: wpr-741081

RESUMO

Hyperamylasemia in patients with lung cancer is relatively rare, occurring in 1-3% of all cases of the disease. The pathogenesis of hyperamylasemia in solid cancers is not clear. In Korea, no cases of hyperamylasemia have been reported in patients with adenocarcinoma of the lung. Instead, the lung cancers in patients with hyperamylasemia have in most cases been adenocarcinomas. We report a case of a 64-year-old woman with hyperamylasemia that was suspected to have been induced by mucinous adenocarcinoma of the lung. The patient's amylase isoenzyme pattern was of the salivary type. Systemic chemotherapy normalized her serum amylase levels and produced a partial response in her lung cancer.


Assuntos
Feminino , Humanos , Pessoa de Meia-Idade , Adenocarcinoma , Adenocarcinoma Mucinoso , Amilases , Hiperamilassemia , Coreia (Geográfico) , Pulmão , Neoplasias Pulmonares
2.
Journal of Rheumatic Diseases ; : 91-94, 2012.
Artigo em Inglês | WPRIM | ID: wpr-15488

RESUMO

Hematologic malignancies and lymphoproliferative disorders have been reported after using tumor necrosis factor-alpha inhibitor in patients suffering from spondyloarthropathy. Previously reported cases were treated by using infliximab and etanercept. Usually, it takes approximately several months for leukemia or lymphoproliferative disorders to occur after the application of those agents. However, we report a case of acute myeloid leukemia that developed after short term usage of adalimumab in a patient suffering from psoriatic arthritis.


Assuntos
Humanos , Anticorpos Monoclonais , Anticorpos Monoclonais Humanizados , Artrite Psoriásica , Neoplasias Hematológicas , Imunoglobulina G , Leucemia , Leucemia Mieloide Aguda , Transtornos Linfoproliferativos , Receptores do Fator de Necrose Tumoral , Espondiloartropatias , Estresse Psicológico , Fator de Necrose Tumoral alfa , Adalimumab , Infliximab , Etanercepte
3.
Korean Journal of Medicine ; : 507-511, 2012.
Artigo em Coreano | WPRIM | ID: wpr-21297

RESUMO

Hyperamylasemia in patients with lung cancer is relatively rare, occurring in 1-3% of all cases of the disease. The pathogenesis of hyperamylasemia in solid cancers is not clear. In Korea, no cases of hyperamylasemia have been reported in patients with adenocarcinoma of the lung. Instead, the lung cancers in patients with hyperamylasemia have in most cases been adenocarcinomas. We report a case of a 64-year-old woman with hyperamylasemia that was suspected to have been induced by mucinous adenocarcinoma of the lung. The patient's amylase isoenzyme pattern was of the salivary type. Systemic chemotherapy normalized her serum amylase levels and produced a partial response in her lung cancer.


Assuntos
Feminino , Humanos , Pessoa de Meia-Idade , Adenocarcinoma , Adenocarcinoma Mucinoso , Amilases , Hiperamilassemia , Coreia (Geográfico) , Pulmão , Neoplasias Pulmonares
4.
Infection and Chemotherapy ; : 80-83, 2012.
Artigo em Coreano | WPRIM | ID: wpr-154688

RESUMO

The genus Alternaria contains several species of melanized hypomycetes that cause opportunistic human infections. The most frequent clinical manifestations of alternariosis are cutaneous and subcutaneous infections, followed by oculomycosis, invasive and non-invasive rhinosinusitis, and onychomycosis. So far, only 17 cases of rhinosinusitis caused by Alternaria species have been reported since 1977. Although several domestic cases of cutaneous alternariosis have been reported, there is no report of Alternaria rhinosinusitis in Korea. The majority of Alternaria rhinosinusitis involves immunocompromised patients. We report the first case of alternariosis in a patient with neutropenia and myelodysplastic syndrome that was treated with endoscopic debridement and a conventional antifungal agent.


Assuntos
Humanos , Alternaria , Alternariose , Desbridamento , Infecções Oculares Fúngicas , Hospedeiro Imunocomprometido , Coreia (Geográfico) , Síndromes Mielodisplásicas , Neutropenia , Onicomicose , Sinusite
5.
Korean Journal of Medicine ; : S268-S272, 2011.
Artigo em Coreano | WPRIM | ID: wpr-152515

RESUMO

Acute promyelocytic leukemia (APL), which is usually defined by the morphological features of the leukemic cells, is characterized by the t(15;17) (q22;q21) chromosomal translocation and disseminated intravascular coagulation. This specific translocation results in a new fusion transcript between the promyelocytic leukemia (PML) gene and the retinoic acid receptor-alpha (RARalpha) gene. Although the presence of this fusion gene can predict a favorable clinical response to all-trans-retinoic-acid (ATRA) treatment, APL with chromosomal translocations other than t(15;17) (q22;q21) is extremely rare and is associated with a poor prognosis. We experienced a case of APL with de novo t(11;19).


Assuntos
Coagulação Intravascular Disseminada , Leucemia , Leucemia Promielocítica Aguda , Patologia Molecular , Prognóstico , Translocação Genética , Tretinoína
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA